MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Ultrasound Imaging and Quantitative Vibro-Acoustic Assessment of Rickets Under the Age of Ten

Withdrawn

Conditions: Rickets

Interventions: Diagnostic Test: Ultrasound with quantitative vibro-acoustic assessment

First Posted Date: 2024-04-26

Last Posted Date: 2024-12-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 45

Registration Number: NCT06385938

Locations: 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Phase 2

Recruiting

Conditions: Indolent B-Cell Non-Hodgkin Lymphoma
Refractory Indolent B-Cell Non-Hodgkin Lymphoma
Recurrent Indolent Non-Hodgkin Lymphoma
Recurrent Indolent B-Cell Non-Hodgkin Lymphoma
Refractory Indolent Non-Hodgkin Lymphoma

Interventions: Procedure: Computed Tomography
Procedure: Endoscopic Procedure
Radiation: Involved-site Radiation Therapy (3 Fractions)
Radiation: Involved-site Radiation Therapy (12 Fractions)
Procedure: Positron Emission Tomography
Other: Questionnaire Administration

First Posted Date: 2024-04-26

Last Posted Date: 2025-05-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT06386315

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, United States

and more 4 locations

3D DL Ozteo in the Detection of Osseous Changes in Patients with Inflammatory Arthritis

Not Applicable

Recruiting

Conditions: Inflammatory Arthritis

Interventions: Device: oZTEo

First Posted Date: 2024-04-25

Last Posted Date: 2024-12-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 25

Registration Number: NCT06383585

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Photoradiation with Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer

Phase 2

Recruiting

Conditions: Locally Advanced Pancreatic Adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
Stage II Pancreatic Cancer AJCC V8
Stage III Pancreatic Cancer AJCC V8
Stage IV Pancreatic Cancer AJCC V8
Unresectable Pancreatic Adenocarcinoma

Interventions: Procedure: Biopsy
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Procedure: Endoscopic Ultrasound
Drug: Fluorouracil
Drug: Irinotecan
Drug: Leucovorin
Procedure: Lymph Node Biopsy
Procedure: Magnetic Resonance Imaging
Drug: Oxaliplatin
Biological: Pembrolizumab
Drug: Photodynamic Therapy
Procedure: Positron Emission Tomography
Other: Questionnaire Administration
Drug: Verteporfin

First Posted Date: 2024-04-24

Last Posted Date: 2024-12-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 25

Registration Number: NCT06381154

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

App-Based Optimization of Long-Term CPAP Adherence and Quality of Life

Not Applicable

Not yet recruiting

Conditions: Obstructive Sleep Apnea

Interventions: Behavioral: SleepWell24 Application

First Posted Date: 2024-04-24

Last Posted Date: 2025-04-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 40

Registration Number: NCT06381115

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Stereotactic Body Radiation Therapy Plus Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy for Treatment of Metastatic, Recurrent Hormone-Sensitive Prostate Cancer, DIVINE Trial

Phase 2

Recruiting

Conditions: Recurrent Castration-Sensitive Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8
Recurrent Prostate Cancer
Castration-resistant Prostate Cancer

Interventions: Drug: Abiraterone
Drug: Apalutamide
Procedure: Biospecimen Collection
Procedure: Bone Scan
Procedure: Computed Tomography
Drug: Darolutamide
Drug: Degarelix
Other: Questionnaire Administration
Drug: Enzalutamide
Radiation: Stereotactic Body Radiation Therapy
Drug: Goserelin
Drug: Histrelin
Drug: Leuprolide
Procedure: Magnetic Resonance Imaging
Other: Patient Observation
Procedure: Positron Emission Tomography
Drug: Prednisone
Drug: Relugolix
Drug: Triptorelin

First Posted Date: 2024-04-23

Last Posted Date: 2025-05-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 220

Registration Number: NCT06378866

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Remote Cognitive Assessment and Wearable Device While Assessing the Impact of Metformin in Patients With History of Cranial Radiation Therapy

Phase 2

Recruiting

Conditions: Malignant Brain Neoplasm

Interventions: Other: Medical Device Usage and Evaluation
Other: Best Practice
Drug: Metformin
Other: Neurocognitive Assessment
Other: Questionnaire Administration

First Posted Date: 2024-04-22

Last Posted Date: 2025-02-27

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT06377696

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment Prostate Cancer

Phase 2

Recruiting

Conditions: Oligometastatic Prostate Carcinoma
Prostate Adenocarcinoma

Interventions: Procedure: Biospecimen Collection
Drug: Abiraterone Acetate
Procedure: Computed Tomography
Procedure: Magnetic Resonance Imaging
Biological: Gonadotropin-releasing Hormone Analog
Procedure: Positron Emission Tomography
Other: Questionnaire Administration
Radiation: Radiation Therapy

First Posted Date: 2024-04-17

Last Posted Date: 2025-03-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 64

Registration Number: NCT06369610

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States

Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia with an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients with Post-Menopausal Bleeding

Recruiting

Conditions: Endometrial Carcinoma

Interventions: Other: Non-Interventional Study

First Posted Date: 2024-04-15

Last Posted Date: 2024-10-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 300

Registration Number: NCT06365905

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Smartphones Aggravating Anxiety Symptoms

Not Applicable

Conditions: Anxiety

Interventions: Behavioral: General decrease in smartphone use
Behavioral: Avoiding Social Media Apps

First Posted Date: 2024-04-11

Last Posted Date: 2025-04-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT06361342

Locations: 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States

Home Terms & Conditions Privacy Policy